Current development of lipid management in Baltic countriesViigimaa, Margus7th Baltic Atherosclerosis Society Congress : [abstracts]2018 / p. 8-9 http://www.ester.ee/record=b4819912*est

Familial hypercholesterolemia management tool in the North Estonia Medical CentreHeinsar, Silver; Viigimaa, Margus7th Baltic Atherosclerosis Society Congress : [abstracts]2018 / p. 34, 37 http://www.ester.ee/record=b4819912*est

History of the Baltic Atherosclerosis SocietyViigimaa, Margus7th Baltic Atherosclerosis Society Congress : [abstracts]2018 / p. 29 http://www.ester.ee/record=b4819912*est

Importance of data quality in nation-wide e-health system for personalized medicine decision support applicationsRoss, Peeter7th Baltic Atherosclerosis Society Congress : [abstracts]2018 / p. 31 http://www.ester.ee/record=b4819912*est

PCSK9 inhibitor causes a reduction in the level of oxidatively modified low-density lipoproteines in patients with atherosclersosisLankin, Vadim Z.; Tikhaze, Alla K.; Chazova, Irina; Viigimaa, Margus7th Baltic Atherosclerosis Society Congress : [abstracts]2018 / p. 38-39 http://www.ester.ee/record=b4819912*est

The metabolic profile of ischemic heart disease patients with or without previous MI by serum 1H NMR is similarTitma, Tiina; Günther, Ulrich L.; Ludwig, Christian; Pikta, Marika; Zemtsovskaja, Galina; Shin, Min-Ji; Viigimaa, Margus; Tanner, Risto; Samoson, Ago7th Baltic Atherosclerosis Society Congress : [abstracts]2018 / p. 47-48 http://www.ester.ee/record=b4819912*est